Lantern Pharma INC Form 4 insider transactions
NASDAQ
Aaron G.L. Fletcher, a director of Lantern Pharma, and related BIOS funds, reported the sale of common stock between February 27 and February 29, 2024.
NASDAQ
Form 4: Lantern Pharma Insider Leslie Kreis and Related Entities Sell Shares in Multiple Transactions
Leslie Kreis, a director and 10% owner of Lantern Pharma, along with related entities including Bios Funds and BP Directors, sold shares of LTRN common stock in a series of transactions from February 27-29, 2024.